Home > Annual Financials > GRANULES INDIA

GRANULES INDIA Financial Statement Analysis
[BOM: 532482|NSE : GRANULES]

The Revenues of GRANULES INDIA have decreased by -0.55% YoY .
The Earnings Per Share (EPS) of GRANULES INDIA has increased by 23.68 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

GRANULES INDIA Last 5 Annual Financial Results
[BOM: 532482|NSE : GRANULES]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹4,482 Cr₹4,506 Cr₹4,512 Cr₹3,765 Cr₹3,238 Cr
Expenses ₹3,536 Cr₹3,650 Cr₹3,599 Cr₹3,043 Cr₹2,382 Cr
Operating Profit (Excl OI) ₹945 Cr₹856 Cr₹913 Cr₹722 Cr₹855 Cr
Other Income ₹13 Cr₹4.40 Cr₹14 Cr₹18 Cr₹27 Cr
Interest ₹103 Cr₹106 Cr₹56 Cr₹23 Cr₹26 Cr
Depreciation ₹226 Cr₹207 Cr₹184 Cr₹159 Cr₹151 Cr
Profit Before Tax ₹660 Cr₹547 Cr₹687 Cr₹558 Cr₹704 Cr
Profit After Tax ₹502 Cr₹405 Cr₹517 Cr₹413 Cr₹549 Cr
Consolidated Net Profit ₹502 Cr₹405 Cr₹517 Cr₹413 Cr₹549 Cr
Earnings Per Share (Rs)₹20.68₹16.72₹21.34₹16.64₹22.18
PAT Margin (%)6.736.1911.4510.9613.91
ROE(%)14.5213.4619.1817.4927.64
ROCE(%)16.1615.6619.6317.3725.42
Total Debt/Equity(x)0.350.380.380.430.39

Key Financials

Market Cap : ₹ 11,551.4 Cr
Revenue (TTM) : ₹ 4,481.6 Cr
Net Profit(TTM) : ₹ 501.5 Cr
EPS (TTM) : ₹ 20.7
P/E (TTM) : 23.0

Industry Peers & Returns1W1M1Y
GRANULES INDIA -4% -3.6% -9.7%
SUN PHARMACEUTICAL INDUSTRIES -0.1% 1.3% 5%
DIVIS LABORATORIES -1.7% 0.5% 47.2%
CIPLA 0.4% -1.5% -1.6%
TORRENT PHARMACEUTICALS -0.2% 9% 13.3%
DR REDDYS LABORATORIES 0.5% -5.7% -9.1%
MANKIND PHARMA -2.5% 12.1% 25%
ZYDUS LIFESCIENCES -0.4% -0.4% -16.2%
LUPIN 0.7% 0.4% 6.7%


GRANULES INDIA Revenues
[BOM: 532482|NSE : GRANULES]

Y-o-Y

-0.55 %

5 Yr CAGR

8.47 %

Years Revenues % Change
Mar2025 ₹4,482 Cr
-0.55
Mar2024 ₹4,506 Cr
-0.12
Mar2023 ₹4,512 Cr
19.84
Mar2022 ₹3,765 Cr
16.29
Mar2021 ₹3,238 Cr -


GRANULES INDIA Operating Profit
[BOM: 532482|NSE : GRANULES]

Y-o-Y

10.43 %

5 Yr CAGR

2.53 %

Years Operating Profit % Change
Mar2025 ₹945 Cr
10.43
Mar2024 ₹856 Cr
-6.28
Mar2023 ₹913 Cr
26.56
Mar2022 ₹722 Cr
-15.62
Mar2021 ₹855 Cr -

Operating Margins
Y-o-Y

11.06 %

5 Yr CAGR

-5.48 %

Years Operating Margin% % Change
Mar2025 21.09%
11.06
Mar2024 18.99%
-6.18
Mar2023 20.24%
5.58
Mar2022 19.17%
-27.44
Mar2021 26.42% -

GRANULES INDIA Profit After Tax
[BOM: 532482|NSE : GRANULES]

Y-o-Y

23.74 %

5 Yr CAGR

-2.26 %

Years Profit After Tax % Change
Mar2025 ₹502 Cr
23.74
Mar2024 ₹405 Cr
-21.54
Mar2023 ₹517 Cr
25.16
Mar2022 ₹413 Cr
-24.88
Mar2021 ₹549 Cr -

PAT Margins
Y-o-Y

8.72 %

5 Yr CAGR

-16.60 %

Years PAT Margin(%) % Change
Mar2025 6.73 %
8.72
Mar2024 6.19 %
-45.94
Mar2023 11.45 %
4.47
Mar2022 10.96 %
-21.21
Mar2021 13.91 % -

GRANULES INDIA Earnings Per Share (EPS)
[BOM: 532482|NSE : GRANULES]

Y-o-Y

23.68 %

5 Yr CAGR

-1.74 %

Years EPS % Change
Mar2025 ₹21
23.68
Mar2024 ₹17
-21.65
Mar2023 ₹21
28.25
Mar2022 ₹17
-24.98
Mar2021 ₹22 -

GRANULES INDIA Return on Capital Employed (ROCE)
[BOM: 532482|NSE : GRANULES]

Y-o-Y

3.19 %

5 Yr CAGR

-10.71 %

Years ROCE % Change
Mar2025 16.16%
3.19
Mar2024 15.66%
-20.22
Mar2023 19.63%
13.01
Mar2022 17.37%
-31.67
Mar2021 25.42% -

GRANULES INDIA Share Price vs Sensex

Current Share Price : ₹476.2
Current MarketCap: ₹ 11,551.4 Cr
Updated EOD on :Jul 24,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
GRANULES INDIA

-4%

-3.6%

-9.7%

SENSEX

-0.1%

0.2%

2.1%

GRANULES INDIA related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE 500 SHARIAH 4.3% 4.3% 1.1%
BSE HEALTHCARE -0.4% 5% 17.5%
BSE 500 -0.5% 0.9% 0.9%
NSE Indices1W1M1Y
NIFTY MIDSMALL HEALTHCARE 0.2% 8.6% 22.7%
NIFTY HEALTHCARE INDEX -0.1% 4.4% 12.5%
NIFTY 500 -0.5% 0.8% 1.6%
NIFTY TOTAL MARKET -0.5% 1% 1.7%
NIFTY PHARMA -0.6% 4% 9.2%

You may also like the below Video Courses


FAQ about GRANULES INDIA Financials


How the annual revenues of GRANULES INDIA have changed ?

The Revenues of GRANULES INDIA have decreased by -0.55% YoY .

How the Earnings per Share (EPS) of GRANULES INDIA have changed?

The Earnings Per Share (EPS) of GRANULES INDIA has increased by 23.68 % YoY .